About
Nurix Therapeutics Inc (NASDAQ:NRIX) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 22 2026
Nurix Therapeutics Announces New Preclinical Data Highlighting Breadth of Targeted Protein Degradation Pipeline at AACR 2026
Apr 8 2026
Nurix Therapeutics Reports First Quarter 2026 Financial Results and Provides a Corporate Update
Apr 7 2026
Nurix Therapeutics to Participate in Upcoming Investor Conference
Mar 23 2026
Nurix Therapeutics Announces Multiple Presentations Showcasing Depth of Research Pipeline and Scientific Leadership at the American Association for Cancer Research (AACR) 2026 Annual Meeting
Jan 28 2026
Nurix Therapeutics Reports Fourth Quarter and Fiscal Year 2025 Financial Results and Provides a Corporate Update
Financials
Revenue
$83.98 M
Market Cap
$1.63 B
EPS
-3.05
Google Übersetzer